Target intelligence / Profile preview

RAB18, member RAS oncogene family pseudogene (ENSG00000233908)

Target: ENSG00000233908

Overview

The entry "RAB18, member RAS oncogene family pseudogene" with abbreviation "ENSG00000233908" appears to be incorrect or problematic. The correct canonical gene for RAB18 (a genuine protein-coding therapeutic target) is ENSG00000099246, not ENSG00000233908. There is no evidence for a pseudogene named "RAB18, member RAS oncogene family" that matches ENSG00000233908 in major gene and protein databases. All available information refers to the active gene and protein "Ras-related protein Rab-18" and not to any pseudogene, and thus this entry is most likely a data or annotation artifact.

Beyond the preview

Go deeper on RAB18, member RAS oncogene family pseudogene (ENSG00000233908).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Explore the programs pursuing this target and their development progress.

Drug candidates
Developers
Development stage

Clinical trials

Follow the clinical studies evaluating therapies directed at this target.

Trial design
Status
Readouts

Competitive landscape

Compare approaches across drug candidates, modalities, and indications.

Programs
Modalities
Indications

Literature & evidence

Investigate the research and source evidence behind target biology and development.

Publications
Sources
Analysis

Patents

Explore patent activity around therapies and technologies addressing this target.

Patents
Assignees
Technologies

Research & analysis

Connect target biology, drug development, and emerging evidence in your research.

Biology
Development news
Analysis

Bring the full picture into focus.

See how Gosset can support your research on RAB18, member RAS oncogene family pseudogene (ENSG00000233908).

Explore the full profile